Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Incyte
Incyte
Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD
Endpoints
Wed, 10/16/19 - 12:23 pm
Incyte
FDA
graft vs host disease
Jakafi
3 Drug Stocks Poised for Gains After Cancer Conference
Investopedia
Sun, 10/6/19 - 12:26 pm
ESMO
cancer
Amgen
Incyte
Bristol-Myers Squibb
ICER pulls report blasting ‘marginal’ RA drugs, citing need to rethink its approach
Fierce Pharma
Wed, 10/2/19 - 11:53 am
ICER
JAK inhibitors
rheumatoid arthritis
AbbVie
Rinvoq
Pfizer
Xeljanz
Incyte
olumiant
Incyte announces first patient treated in phase 3 trial program evaluating Ruxolitinib cream in patients with vitiligo
Pharmaceutical Business Review
Thu, 09/26/19 - 07:42 pm
Incyte
clinical trials
ruxolitinib
vitiligo
The Week Ahead In Biotech: Spotlight On ESMO Conference
Yahoo/Benzinga
Sun, 09/22/19 - 11:10 pm
JNJ
daratumumab
Urogen
Rhythm Pharmaceuticals
Anavex
Aravive Biologics
TrovaGene
Incyte
AstraZeneca
Roche
Amgen
Aslan
G1 Therapeutics
GSK
Calithera Biosciences
Seattle Genetics
Immunomedics
Checkpoint Therapeutics
Aileron Therapeutics
Genocea Biosciences
AbbVie
Zymeworks
This Could Be a Big Year for Incyte
Motley Fool
Wed, 09/18/19 - 06:52 pm
Incyte
Jakafi
blood cancers
Novartis’ lung cancer drug edges closer to market after FDA grants fast review
Pharmaforum
Fri, 09/6/19 - 12:27 pm
Novartis
Incyte
FDA
breakthrough therapy
non-small cell lung cancer
Zai builds cancer combo strategy with rights to Incyte's PD-1 mAb
BioCentury
Wed, 07/3/19 - 12:07 am
Zai Lab
China
PD-1 inhibitors
Incyte
Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose
Fierce Pharma
Wed, 06/12/19 - 06:43 pm
Eli Lilly
Incyte
olumiant
safety data
Humira
rheumatoid arthritis
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
#ASCO19: MET inhibitors from Incyte/Novartis and Germany's Merck face off for rare subset of NSCLC patients
Endpoints
Tue, 06/4/19 - 12:16 pm
Novartis
ASCO 2019
Incyte
MET inhibitors
capmatinib
non-small cell lung cancer
Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi
Yahoo/Zacks.com
Tue, 05/28/19 - 10:07 am
FDA
Incyte
Jakafi
graft vs host disease
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Biotech Companies Provide High Median Salaries, Analysis Shows
BioSpace
Thu, 05/9/19 - 11:07 pm
salaries
biotech
Incyte
Celgene
Vertex Pharmaceuticals
Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline
Endpoints
Tue, 04/30/19 - 08:57 pm
Incyte
olumiant
baricitinib
FDA
Eli Lilly
Incyte Down as FDA Extends Review Period of Jakafi for GVHD
Yahoo/Zacks.com
Sat, 02/9/19 - 12:23 pm
Incyte
FDA
Jakafi
graft vs host disease
Lilly and Incyte's Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials
BioSpace
Mon, 02/4/19 - 11:49 am
Eli Lilly
Incyte
olumiant
atopic dermatitis
clinical trials
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter
Investors Business Daily
Wed, 01/16/19 - 11:55 am
Incyte
M&A
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »